Regeneron Pharmaceuticals | REGN - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
AbbVie USD 10.77B 4.2B 2026-09
Agenus USD 18.74M 16.26M 2026-06
Agios Pharmaceuticals USD 128.55M 28.9M 2026-09
Alnylam Pharmaceuticals USD 1.75B 46.02M 2026-09
Amgen USD 13.19B 799M 2026-09
Astellas Pharma JPY 244.7B 36.91B 2026-06
AstraZeneca USD 4.89B 2.67B 2026-06
Biogen USD 1.3B 18.9M 2026-09
BioMarin Pharmaceutical USD 736.01M 138M 2026-09
Bristol-Myers Squibb USD 9.57B 852M 2026-09
Eli Lilly USD 4.89B 4.07B 2026-09
Gilead Sciences USD 3.18B 4.45B 2026-06
GlaxoSmithKline GBP 3.1B 337M 2026-06
Incyte USD 3.85B 127.8M 2026-09
Ionis Pharmaceuticals USD 296.3M 53.76M 2026-09
J&J USD 16.91B 3.51B 2026-09
Kyowa Hakko Kirin JPY 249.52B 30.75B 2026-03
Merck USD 9.55B 2.7B 2026-09
Moderna USD 1.2B 528M 2026-09
Neurocrine Biosciences USD 641.5M 309.1M 2026-09
Novartis USD 8.87B 1.25B 2026-09
Novartis USD 8.87B 1.99B 2026-09
Pfizer USD 1.82B 848M 2026-09
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 3.66B 1.2B 2026-09
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06
Sarepta Therapeutics USD 472.76M 98.39M 2026-09
Teva Pharmaceutical Industries USD 4.08B 430M 2026-09
Ultragenyx Pharmaceutical USD 150M 25M 2026-09
United Therapeutics USD 1.19B 614.3M 2026-09
Vertex Pharmaceuticals USD 6.3B 1.55B 2026-09